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Abstract
Cartilage is an essential component of human body, and it is present in any region of 
the body. Auricular cartilages play an essential role in esthetic aspect and shape of the 
face. Therefore, comprehensive understanding of the applied basic science of the carti-
lage of the ear is essential to understand the pathophysiology of diseases that occur in 
this region, how much it is resistant to infections and invasion by malignancies and how 
postsurgical and postinfection healing happen.
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1. Introduction
In this chapter, the practical aspects of the applied basic surgical science of the auricular car-
tilage are discussed on an evidence-based level according to the most recent researches in the 
literature.
Ear pinna (auricle) is an extremely important organ not only for the facial aesthesis but also 
plays a major role in hearing physiology. Both functions rely primarily on the biomechanical 
nature of the cartilage. Degrees of inclination and angles at its attachment to the skull deter-
mine the shape of the head and the auditory function especially the ability to localize the 
direction of sound.
In addition, auricular cartilage is vulnerable to many congenital and acquired diseases that 
require cartilage replacement or excision; this has opened the door for many advances in tis-
sue engineering to happen. Moreover, healthy cartilage of the auricle is a plentiful source of 
cartilage for reconstruction of the nose, skull base and facial defects.
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativeco mons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Consequently, comprehensive knowledge about recent advances in literature about basic sci-
ence of this critical piece of cartilage is of paramount importance. In this chapter, précised, 
focused and between lines pieces of information will be mentioned, but old and repeated ones 
will not. The chapter aims to know how basic physiology, pathology, biomechanics and bio-
chemists of the auricular cartilage can be applied to the clinical perspectives. It is not a pure 
clinical chapter; only related points that can be applied to the clinical practice are discussed.
Based on the abovementioned perspectives, the reader of this chapter is expected to acquire 
detailed knowledge about:
• Microarchitecture of the auricular cartilage and applied physiological aspect of the chon-
drocyte and matrix,
• Response of auricular cartilage to relapsing polychondritis as the most common autoim-
mune disorder affects the auricular cartilage,
• Effect of ischemia on the cartilage,
• Pathophysiology of infective chondritis and perichondritis,
• Molecular biology of invasion of the cartilage by malignancies,
• Effect of surgical intervention and trauma on the cartilage,
• Healing of auricular cartilage after surgery and trauma,
• Healing of the graft in auricle and
• Aberration of healing.
Reader also will be provided, at the end of the chapter, with an “at a glance section” that sum-
marizes the most important advances in understandings.
2. Microstructure of auricular cartilage
The auricle is a funnel-shaped cartilaginous structure consists of a single thin plate of elastic 
fibrocartilage covered by skin and it is continuous with the meatus of the external auditory. 
It is also characterized by ridges and depressions formed by the auricular cartilage; there are 
five regions caused by this molding such as helix, antihelix, tragus, antitragus and concha [1].
Auricular cartilage consists of cartilage cells fill small lacunar spaces in the matrix. Young 
cells, called chondroblasts, are relatively small and flat and have an irregular edge with pseu-
dopodic-type extensions lodged in the matrix. Postmitotic chondroblasts have intercellular 
contact and are absorbed with matrix synthesis. The chondrocytes are mature cells that grow 
and become spheroid with age and lose the extensions [2].
The matrix is composed chiefly of water, proteoglycans, lipids and collagens. The substance 
is a firm gel, positive to periodic acid-Schiff reaction, and metachromatically to toluidine blue. 
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The glycoproteins are a series of mucoprotein copolymers, conjoined in large lateral chains 
without rami, of condroitin-4-sulfate glycosaminoglycans, condroitin-6-sulfate and keratin 
sulfate. The proportions are modified with age, keratan sulfate increases with age [3].
The resistance to compression and the viscoelasticity are referred to their content of glycos-
aminoglycans, and the resistance to tension of the collagen and elastic fibers content.
2.1. Applied surgical physiology of human chondrocytes
However, porcine and bovine chondrocytes were used for many years in the tissue engineering 
of human auricular cartilage; human auricular chondrocytes have become the procedures of 
production of elastic cartilage in vitro. This has changed the future of auricular reconstruction 
via its marked ability to grow in tissue culture and marked ability to produce matrix of both hya-
line and elastic cartilage. Human chondrocytes have the following criteria in the tissue cultures:
1. They have ability to lay down large amount of elastic cartilage under certain circumstances. 
Alginate-suspended aggregated chondrocytes produce matrix that contained elastin (the hall-
mark of the original elastic cartilage) and this amount of auricular elastic cartilage increase 
markedly with the alginate/collagen-containing hydrogen and enriched with k-elastin [4].
2. It can also be stimulated with insulin, dexamethasone, or growth factors such as bFGF, 
PDGFbb, EGF, and IGF(2.3), what is more is their ability to continue growth in the subcu-
taneous pocket.
3. The neo-cartilage, produced by cultured chondrocytes, does not dedifferentiate or degen-
erate after long cultivation time (12 weeks) and it has the same immunohistochemistry 
properties as the native auricular cartilage.
4. Cartilages can be created in predetermined shapes and dimensions using chondrocyte 
transplantation on appropriate polymer templates [4].
Ability of human auricular chondrocytes to proliferate in tissue cultures to produce auricular 
cartilage molds with the same histological and mechanical criteria, and the same predeter-
mined configuration have changed surgical approaches in clinical situations such as anotia, 
microtia, traumatic loss and cauliflower ears. This also has replaced old-fashioned methods 
such as costal cartilage grafting, which was mandating the timing of surgery to be delayed 
until the age of 6–10 [5], and carry the risk of pneumothorax and chest wall deformities [6].
2.2. Applied surgical physiology of auricular cartilage matrix
As mentioned earlier, the biochemical composition of matrix is the factor that determines the bio-
mechanical properties such as wear resistance, load bearing and shock absorption [7]. The mechan-
ical properties of the auricular cartilage have not been extensively studied to date, but the Young’s 
modulus was determined by tension calculating a modulus value for concha and tragal cartilage to 
be 3.4 and 2.8 MPa, respectively, but the difference was not significant [8]; however, the concha was 
found to demonstrate a greater Young’s elastic modulus in comparison to the helix [9].
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In addition, the final stress relaxation rate was similar for all five regions of the auricular carti-
lage, suggesting that all regions of the auricle had the ability to reach similar load equilibrium 
over 15 min (helix 1.78 × 10−4 ± 0.32 MPa/s, antihelix 1.62 × 10−4 ± 0.31 MPa/s, concha MPa/s 
1.52 × 10−4 ± 0.23 MPa/s, antitragus 1.46 × 10−4 ± 0.23 MPa/s and tragus 1.46 × 10−4 ± 0.15 MPa/s). 
The final absolute relaxation was also similar between the five regions of the auricular carti-
lage, demonstrating that the auricular cartilages could relax to a similar final stress level (helix 
0.21 ± 0.02 MPa, antihelix 0.24 ± 0.04 MPa, concha 0.23 ± 0.04 MPa, antitragus 0.21 ± 0.03 MPa 
and tragus 0.23 ± 0.03 MPa) [8–10]. Therefore, surgeons can harvest any anatomical part of the 
auricle for reconstruction.
Such biomechanical properties are mainly due to collagen II fibers in the matrix because Dahl 
et al. analyzed the bimolecular composition of endogenous auricular cartilage in normal 
adults, pediatric patients with microtia and pediatric patients with preauricular appendages. 
Immunohistochemical analysis demonstrated similar levels and distribution of elastin and 
collagens I and X in all three groups of patients, and reduced expression of collagen II in chil-
dren with microtia [11]. Collagen II is, also, the main target affected in several diseases and 
malignancies, which is discussed in the following paragraphs.
As mentioned earlier, reconstructive surgeon should use synthetic or tissue engineered car-
tilage that provides the anatomical and biomechanical properties of the human auricle to 
achieve good biocompatibility with the skin [12], adequate mechanical properties prevent 
deformation of the implant when implanted beneath the skin providing definition of the 
auricle shape. Also, similar mechanical properties to the surrounding tissue prevent stress at 
the interface [1]; mechanical mismatch can lead to micromovement between the skin and the 
implant when subcutaneously implanted [13], thus implant failure and extrusion.




The most common disease of this type is the relapsing polychondritis (RP) that results from 
autoimmune reaction against collagen fibers of the cartilage. In addition, there is a condition 
that must be known to differentiate it from malignancies of the skin and cartilage, it is the 
“chondrodermatitis nodularis chronica helicis” or “Winkler’s disease,” which results from 
ischemia of the cartilage.
3.1.1.1. Relapsing polychondritis
Relapsing polychondritis (RP) is a rare multisystem autoimmune disease characterized by 
recurrent episodes of inflammation and progressive destruction of cartilaginous tissues, elas-
tic cartilage of the ears and nose, hyaline cartilage of peripheral joints, vertebral fibrocartilage 
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and tracheobronchial cartilage [14, 15]. Auricular chondritis occurs in 20% of patients at pre-
sentation and in 90% at some point during the course of the disease [15]; therefore, its applied 
pathophysiology will be discussed with some details in the following context. Etiology of RP 
is unknown but the pathogenesis is mostly due to an immunologic reaction to type II collagen 
in all human tissues [16, 17].
Collagen type II is the main target of the autoantibodies in RP; therefore, it is the initial step 
that induces the chondritis; this is approved by the fact that titers against the native type 
II collagen were substantially higher than titers against constituent alpha-1 (II) chains and 
antibodies are positive in 30% of cases [17]. This observation suggests that the antibodies 
were not formed after destruction of cartilage and denaturation of collagen [16]. However, 
not only autoantibodies against type II collagen have been detected in patients with RP but 
also autoantibodies against type IX and XI collagen have been found in a patient with RP [18]. 
In addition, recently auto antibodies against other cartilage proteins such as cartilage oligo-
meric matrix proteins(COMP) and matrilin-1 have been found; matrilin-1 is a cartilage matrix 
protein expressed at high levels in the tracheal, nasal, auricular and chondrosternal cartilage 
[19, 20]. Such antibodies activate both humoral and cellular immunoreaction; there are sev-
eral evidences to support this [21]:
1. Damaged cartilage is infiltrated by CD4 + T-cells and plasma cells and contains immune 
deposits and perichondral infiltrate of lymphocytes and plasma cells with loss of baso-
philic staining of the cartilage matrix indicating loss of proteoglycans [22].
2. A T-cell response specific to peptides found in collagen type II (which contributes 95% of 
all cartilage collagen) or of matrilin-1 is found in some patients [23].
3. Over half the patients with RP carry the HLA-DR4 antigen [24, 25].
4. In one patient, oral administration of collagen type II for desensitization was apparently 
effective [26].
These reactions lead to severe chondritis by recruiting inflammatory cells to the cartilage, such 
recruitment is orchestrated by a complex cytokine network [27] such as interferon-Υ, interleu-
kin [IL]-2, and IL-12 [28] in addition to soluble triggering receptor (sTREM-1) expressed on 
myeloid cells 1, chemokine (C-C motif) ligand 4 (CCL4), vascular endothelial growth factor 
(VEGF) and matrix metalloproteinases-3 (MMP-3) [29].
As a result of this autoimmune reaction, many proteases are released from the inflammatory 
cells [21] and by chondrocytes that undergo apoptosis by the effect of MMP-3 [30], causing 
destruction of cartilage matrix and leading to the characteristic features of RP of the auricle.
Because collagen II is responsible for biomechanical criteria of the auricle, after repeated 
attacks or sometimes after a single prolonged episode, the cartilaginous structure of the ear is 
damaged and the pinna not only feels flabby but also may droop or even flop up and down 
when the patient walks [15]. Pinna also may hardened by calcifications or ossification of the 
connective scar tissue that replaces the cartilage. Cauliflower ear deformity occurs in about 
10% of patients [22].
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3.1.1.2. Chondrodermatitis nodularis chronica helicis (Winkler’s disease)
Another noninfective inflammatory reaction related to the unique criteria of the cartilage in 
general and auricular cartilage in specific is an inflammatory lesion called chondrodermatitis 
nodularis chronica helicis. It is a chronic perichondritis, which is thought to be related to limited 
vascularity at the lateral and anterior aspect of the auricle. The skin is tightly stretched over the 
underlying cartilage with minimal subcutaneous tissue, which results in limited vascularity and 
ischemia which is thought to promote the development of this lesion [31]. Another related the-
ory is the perichondrial vacuities which narrows the blood vessels and induce ischemia of the 
cartilage, leading to the clinical picture of the given disease [32]. Mostly located on the helix, this 
disease is characterized by a hard nodule which involves the skin and the cartilage of the ear.
Ischemia also can result from compression on the cartilage as in infection and hematoma, 
which are discussed in the following paragraphs.
3.1.2. Infective inflammatory conditions (perichondritis and chondritis)
Perichondritis and chondritis represent infections of the auricular perichondrium or cartilage. 
It is caused by blunt or penetrating trauma to the ear or by direct extension from an otitis 
externa. Penetrating trauma may result from various injuries, including ear piercing, assaults, 
bites and iatrogenic injuries. Iatrogenic infection occurs when the cartilage and soft tissues 
of the ear are employed as donor sites for tissue used in the repair of defects of the nose and 
external ear [33]. The increasingly popular piercing of the ear cartilage as opposed to the 
lobule may predispose to infection [34], and outbreaks have been reported and Pseudomonas 
is the most frequent causative organism [35]. Burn of the auricle is the most aggressive form 
because it makes the cartilage most vulnerable to infective chondritis due to presence of large 
amount of dead cartilage tissues.
Whatever the reason of chondritis, cartilage becomes intensely infiltrated with polymorpho-
nuclear leukocytes and phagocytes, which damage the cartilage via its cytokines and inflam-
matory mediators [36] such as auricular cartilage, like any cartilage, lack of vascular supply; 
it is only supplied from the overlaying perichondrium that makes it vulnerable to ischemia 
and necrosis. In addition, intact perichondrium adds to the problem because it does not allow 
the inflammatory edema of the cartilage to expand, increasing the pressure on the cartilage 
which causes more necrosis and end up with cauliflower ear [37]. This pathophysiology must 
be applied clinically by immediate drainage of abscess and hematoma, and adequate debride-
ment of any dead cartilage [38].
3.2. Auricular cartilage and malignancy
Cancer of the auricle accounts for around 6% of all cutaneous malignancies, out of which 
50–60% are squamous cell carcinoma, 30–40% is basal cell carcinoma (BCC) and 2–6% is 
malignant melanomas. [39] These malignancies can invade the cartilage of the auricle via sev-
eral mechanisms but the most recent mechanism rather than the direct tissue pressure effect 
is the role played by mediators released by the tumors.
Matrix metalloproteases (MMP) play an integral role in tumor growth and metastasis; MMPs 
are a family of zinc-dependent endopeptidases. They allow tumors to grow by degrading 
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matrix barriers of the underlying cartilage and promoting angiogenesis as well as releasing 
active growth factors and modulating apoptosis; therefore, they are used as tumor markers 
malignant transformation of keratinocytes [40, 41]. Specifically, MMP-13 is associated with 
greater metastatic capacity and MMP-11 is linked to increased local invasiveness of SCC of 
the head and neck. MMP-13 (collagenase 3) preferentially degrades type II collagen found 
in cartilage [42]. In cSCC, MMP-13 collocates with laminin-5, which is normally founded in 
the basement membrane to promote keratinocyte motility to the edge of the lesion and sub-
sequently degrades nearby tissue, allowing tumor invasion [43, 44]. Therefore, matrix of the 
cartilage in the auricle is an important risk factor for the squamous cell carcinoma which 
releases many proteolytic enzymes to facilitate invasion and spread.
4. Healing of auricular cartilage
4.1. Normal healing
Cartilage injuries can be caused by several reasons because it is liable to trauma and several 
surgical procedures; it is capacious source of highly resistant cartilage, it is also liable to sev-
eral disfiguring congenital anomalies that necessitate plastic surgeries that require grafts to 
the auricle to close defects [45]. Despite the widely spread use of those grafts in auricular car-
tilage defects, insufficient union and loss of grafting material through absorption in the long 
run has regularly been reported [46].
In addition, damage associated with traumatic injuries or extensive surgical manipulation is 
characterized by catastrophic disruption of cartilage matrix integrity and structure, extensive 
chondrocyte death in the area of cartilage injury, and expansion of this “zone of injury,” which 
is facilitated by diffusible mediators such as nitric oxide [47]. The main reason behind this is that 
the body does not heal isolated cartilage damage effectively because blood supply necessary for 
the initiation and support of the repair process is absent, a lack of sufficient stem cells to repopu-
late and repair the defect, and chondrocyte cell death in the surrounding cartilage which com-
promises tissue integrity and interferes with repair tissue integration [47]. Viable chondrocytes 
near the injury may proliferate, form clusters of new cells, and synthesize new matrix, but chon-
drocytes cannot migrate readily through cartilage tissue to the site of the injury, and the matrix 
components they synthesize usually are not sufficient to fill the defect [47]. To conclude, any 
cartilage wound healing response that does not lead to replacement of type II collagen and pro-
teoglycan synthesis will result in tissue with abnormal morphologic and mechanical properties 
[48]. Unfortunately, this is the case when the basic healing process of the cartilage was studied.
Pathophysiology of healing of hyaline cartilage (auricular) can be classified according to the 
reason of injury:
i. Postsurgical and posttraumatic healing
General healing process of the cartilage is in the young rabbit, traumatization of cartilage 
perpendicular to its surface resulted within 3 days in regression and necrosis of the tissue, 
lining the cut end, which is neighbored by a zone of hyperactivity and increased mitosis. On 
the seventh day, filaments present in the matrix are arranged in bundles, which demarcate 
the border between the viable cartilage and the regressive zone; they are continuous with the 
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perichondrial fibers [49], the necrotic material is invaded by macrophages and polymorpho-
nuclear cells from the contiguous exudate. In later stages, this zone has developed into a firm 
layer of fibrous tissue. After 4–6 weeks, the demarcating fibers will cover the rounded stump, 
protecting the cartilage fragment. However, all these reactions are absent in adult rabbits 
making the cartilage not to heal [50].
ii. Healing of grafting to the auricle (healing at interface between graft and auricular cartilage)
Wound healing of the incision surface of the graft was similar to the reaction in the pre-existent 
cartilage, described earlier. Thus, the scarring occurred on both sides of the junction and there-
fore, the junction was in most cases, fibrous and not cartilaginous. In addition, the subcutane-
ous transplant site in the head and neck lead to strong inflammatory reactions and resorption 
of the bioartificial cartilage in contrast to orthopedic and trauma surgery where the engineered 
constructs or autologous chondrocytes are placed in the immunoprivileged region of joints [51].
To conclude, the end result of healing depends on the age of the patient, direction and depth 
of the wound as the following:
1. Large, complete-thickness defects do not heal easily; normal healing time for ear cartilage 
piercing is 2 months to 1 year, so intervention is a must [52].
2. Partial-thickness defects are normally repaired by deposition of fibrous scar tissue.
3. Small, full-thickness cartilage defects are replaced by fibrocartilage. The mechanism of 
fibrocartilaginous repair appears to be mediated by proliferation and differentiation of 
mesenchymal cells of the marrow [53].
Consequently, it is inevitable to find a method that enhances cartilage tissue healing or to 
replace the damaged cartilage as following:
1. Biologic grafts such as perichondrium have been successfully used to repair full-thickness 
defects, probably because the inner layer of the perichondrium, adjacent to the cartilage 
contains progenitor cells that can differentiate into chondroblasts [52]. However, the outer 
layer rapidly produces fibrous overgrowth, preventing the good cartilage-to-cartilage con-
nection necessary to restore the mechanical function of the structure [54].
2. Tissue engineered cartilage molds can be used, as mentioned in Section 2.1.
3. Growth factors to enhance healing such as somatomedin-C have growth-promoting effect 
on cartilage [46]. In addition, such products that induce chondrogenesis can be produced 
via gene therapy. Gene therapy approaches to cartilage repair are encouraged by the ability 
of various gene products to enhance chondrogenesis [55]. Examples include growth factors 
[56] such as insulin-like growth factor-1 (IGF-1), transforming growth factor-β (TGF-β), 
fibroblast growth factors and various members of the BMP family, as well as transcription 
factors such as SOX-9 [57], certain signaling molecules such as SMADs [58], and molecules 
that inhibit apoptosis such as BCL-2 [59]. However, it is still difficult to administer them 
exogenously to sites of cartilage injury in a sustained and therapeutically useful manner.
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4.2. Aberrant healing of the cartilage
Any surgical intervention, especially ear piercing, may complicate with keloid which repre-
sent one extreme of aberrant dermal wound healing that is observed only in susceptible indi-
viduals following cutaneous injury [60] with higher incidence during puberty and pregnancy, 
periods with hyperactivity of the pituitary gland [61]. Due to increased release of greater 
melanocyte stimulating hormone (MSH), keloid formation mainly occurs in parts of the body 
with high concentrations of melanocytes [62].
Histopathologically, keloid is included in the spectrum of fibroproliferative disorders and 
commonly affects the ears, it has been suggested that keloid scarring is caused by an inability to 
stop the wound healing process and abnormal response to inflammation by fibroblasts [63, 64]. 
Scar is densely populated by inflammatory cells, which release fibrogenic factors such as 
transforming growth factor (TGF)-β1 and -β2. This environment enhances accumulation of 
ECM, while its degradation is impaired (via decreased levels of TGF-β3 and matrix metallo-
proteinases [MMP], for example, (MMP-9) [65]. In addition, development of a Th-2 response 
stimulates fibrogenesis and Th-1 predominance attenuates the tissue fibrosis [66, 67].
To conclude, author summarizes this chapter in the following points, which include the latest 
research findings in literature about the above discussed issue.
5. At a glance
1. Both functions of the auricle, atheistic and hearing, rely primarily on the biomechanical 
nature of its cartilage.
2. Human auricular chondrocytes have become the procedures for the production of elastic 
cartilage in vitro because they lay down large amount of elastic cartilage under certain 
circumstances.
3. Cartilage of human chondrocytes culture is resistant to degeneration even after long time 
and it has the same immunohistochemistry properties the native auricular cartilage.
4. The final stress relaxation rate is similar for all five regions of the auricular cartilage; all 
regions of the auricle had the ability to reach similar load equilibrium over 15 min.
5. Biomechanical properties of the auricular cartilage are mainly due to collagen II fibers in 
the matrix which is defective in patients of congenital auricular malformations.
6. Implants must have the same mechanical properties of the cartilage otherwise mechani-
cal mismatch can lead to micromovement between the skin and the implant thus implant 
failure and extrusion.
7. Collagen type II is the main target of the autoantibodies in relapsing polychondritis (RP); 
therefore, it is the initial step that induces the chondritis.
8. Recently, autoantibodies against cartilage oligomeric matrix proteins (COMP) and matri-
lin-1 have been found in patients of (RP).
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9. However, not many experiments, oral administration of collagen type II for desensitiza-
tion in (RP) is apparently effective.
10. Chondrodermatitis nodularis chronica helicis is proven to be partially due to ischemia of 
the cartilage.
11. Intact perichondrium in auricular perichondritis and hematoma adds to the problem be-
cause it does not allow the inflammatory edema or blood, respectively, to expand, increasing 
the pressure on the cartilage, which causes more necrosis and end up with cauliflower ear.
12. MMP-13 (collagenase 3) preferentially degrades type II collagen found in cartilage.
13. In cSCC, MMP-13 collocates with laminin-5, which is normally found in the basement 
membrane to promote keratinocyte motility to the edge of the lesion and subsequently 
degrades nearby tissue, allowing tumor invasion.
14. Chondrocytes cannot migrate readily through cartilage tissue to the site of the injury, and 
the matrix components they synthesize usually are not sufficient to fill the defect.
15. Healing of the cartilage depends on the age of the patient, direction and depth of the 
wound; large, complete-thickness defects do not heal easily and intervention is a must.
16. Subcutaneous transplant site in the head and neck lead to strong inflammatory reactions 
and resorption of the bioartificial cartilage in contrast to orthopedic and trauma surgery 
where the engineered constructs or autologous chondrocytes are placed in the immuno-
privileged region of joints.
17. Keloid is one extreme of aberrant dermal wound healing that is observed only in suscep-
tible individuals following cutaneous injury.
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